Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
67,505 Ulefnersen (ION-363), an antisense therapy targeting the FUS gene, is currently in Phase III trials for FUS-ALS
Bn cnh chc nng sinh l, testosterone cn nh hng n s pht trin ca c bp v mc lng trn c th
She has no significant past medical history or comorbidities
While your body gets to work right away, visible results take time to appear
While mechanistically interesting, stacking three or more compounds dramatically increases complexity, cost, and potential for unexpected interactions
US$ 21.68
US$ 26.70
US$ 27.39
US$ 27.29
US$ 21.37
US$ 22.91
US$ 25.12
